Share >  
Share
Share on Tumblr

Gsk Pharma

News »

   latest by relevance
GSK Pharma Q1 net up 37% to Rs 169cr, shares rally
May 07, 2013 at 13:49 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals' first quarter (January-March) net profit rose by 37.4 percent year-on-year to Rs 169 crore, sending its shares 6 percent higher.
Pharma cos likely to post 21% EBITDA growth in Q4: MOST
Apr 16, 2013 at 13:30 | Source: Moneycontrol.com
Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY and EBITDA growth of 21.3% YoY for our pharma universe (excluding one-offs).
GSK Pharma appointed non-executive independent director
Feb 19, 2013 at 19:15 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that at the Meeting of the 0Board of Directors of the Company held on February 19, 2013, Ms. Anjali P. Bansal has been appointed as Non-Executive Independent Director with effect from February 19, 2013 in the casual vacancy caused due to resignation of Mr. V. Narayanan.
GSK Pharma fixes book closure for dividend
Feb 19, 2013 at 15:23 | Source: Moneycontrol.com
The Register of Members & Share Transfer Books of GlaxoSmithKline Pharmaceuticals will remain closed from April 08, 2013 to April 16, 2013 (both days inclusive) for the purpose of Payment of Dividend. The dividend will be payable on April 17, 2013.
Buy GSK Pharma; target of Rs 2277: Motilal Oswal
Nov 29, 2012 at 13:37 | Source: Moneycontrol.com
Motilal Oswal is bullish on GlaxoSmithKline Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 2277 in its November 27, 2012 research report.
Drug pricing policy: Pharma majors may see impact of 5-10%
Nov 28, 2012 at 11:48 | Source: Moneycontrol.com
Prabhudas Lilladher has come out with its report on pharma space. According to research firm the current policy, Cipla, Dr Reddys Lab, Ranbaxy, GSK Pharmas revenue from domestic formulation is likely to be impacted by 5-10%.

Videos »
Brought GSK board to see India's potential: CEO Witty
Buy Apollo Hospitals, Bosch, GSK Pharma: Agarwal
Indian pharma cos welcome 'outsiders' to up global presence
Business to grow Rs 1000cr in FY11: Stride Arcolab
What is Lupin's acquisition agenda for the future?
more »

Photos »

  /  
News across the web »
Drug Price Control Order puts pharma stocks under some pressure
Coimbatore, May 17: Pharma stocks were under some pressure in the morning trade following the issue of Drug Price Control Order by the Central Government which is likely to impact drug prices. But th...
May 17, 2013 at 11:02 | Source: The Hindu BusinessLine
Largecaps lift Nifty past 6000, Sensex rallies 215 points
Investors kept up their buying spree Tuesday, lifting benchmark indices to three month high, and pushing the Sensex closer to the psychological 20,000 mark. The Nifty closed above its key technical l...
May 07, 2013 at 16:57 | Source: DomainB
GSK Pharma: Book profit
May 4, 2013: Margin pressure, pricing policy risk and rich valuations may hold back the stock of multinational pharma major GlaxoSmithKline Pharma. The stock currently trades at 24.5 times its 2014 e...
May 04, 2013 at 22:31 | Source: The Hindu BusinessLine
Pharma MNCs current spend on R D in India not significant
Following the Supreme Court order rejecting its patent plea on cancer drug Glivec, Novartis India said it would not invest on research and development (R&D) in India and move it to favourable destinat...
Apr 02, 2013 at 12:56 | Source: Economic Times
Top three MNC pharma cos Novartis, Pfizer and Abbott lose 10% in 2013
NEW DELHI: It is probably the most challenging time for a multinational pharma company in India post the rejection of the Glivec patent which has added more woes to these companies. Top three MNC pha...
Apr 02, 2013 at 12:20 | Source: Economic Times
more »
Interact & exchange stock tips & market info »

Guest

GlaxoSmithKline  

There are many MNCs, such as Bata India, Colgate-Palmolive, Cummins In...

11.18 AM May 13th

MOSL Advisory (Authenticated User)

Platinum Member

2572 Followers

GlaxoSmithKline  

GSK Pharma`s (GLXO) 1QCY13 performance was below estimat...

5.37 PM May 9th

MMB Messenger

Platinum Member

172201 Followers

GlaxoSmithKline  

Will you add GSK Pharma to your portfolio?

1.49 PM May 7th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window